Kate Young

1.3k total citations
30 papers, 365 citations indexed

About

Kate Young is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kate Young has authored 30 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Kate Young's work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Kate Young is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Kate Young collaborates with scholars based in United Kingdom, United States and Australia. Kate Young's co-authors include Naureen Starling, David Cunningham, Anna Minchom, James Larkin, Ian Chau, D.J. Hughes, Daniel L. Morganstein, Emma Kipps, Gilberto Lopes and Joel E. Segel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Kate Young

26 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Young United Kingdom 11 240 115 92 64 45 30 365
Fenglong Bie China 13 211 0.9× 155 1.3× 143 1.6× 66 1.0× 88 2.0× 32 429
Shuichi Tsukamoto Japan 11 132 0.6× 106 0.9× 107 1.2× 58 0.9× 48 1.1× 23 333
Yasunori Deguchi Japan 10 153 0.6× 160 1.4× 104 1.1× 49 0.8× 43 1.0× 16 352
Hirofumi Rokutan Japan 10 144 0.6× 120 1.0× 170 1.8× 74 1.2× 48 1.1× 24 370
Yang Lv China 12 189 0.8× 80 0.7× 98 1.1× 91 1.4× 76 1.7× 24 312
Ei Yamaki Japan 8 143 0.6× 133 1.2× 129 1.4× 52 0.8× 45 1.0× 29 367
Edwin A. Basak Netherlands 10 318 1.3× 92 0.8× 52 0.6× 44 0.7× 44 1.0× 18 403
Ashish Manne United States 10 300 1.3× 100 0.9× 57 0.6× 47 0.7× 41 0.9× 44 430
Keiichi Akahoshi Japan 12 216 0.9× 101 0.9× 139 1.5× 140 2.2× 80 1.8× 49 445

Countries citing papers authored by Kate Young

Since Specialization
Citations

This map shows the geographic impact of Kate Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Young more than expected).

Fields of papers citing papers by Kate Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Young. The network helps show where Kate Young may publish in the future.

Co-authorship network of co-authors of Kate Young

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Young. A scholar is included among the top collaborators of Kate Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Young. Kate Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pozas, Javier, James Larkin, Anna Olsson‐Brown, et al.. (2025). Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. Cancers. 17(15). 2461–2461.
2.
Carr, Aisling, Frederick W. Vonberg, Kate Young, et al.. (2024). Neurological complications of immune checkpoint inhibitors: a practical guide. Practical Neurology. 25(2). 116–126. 7 indexed citations
3.
Andrés, María Sol, Muhummad Sohaib Nazir, Stuart D. Rosen, et al.. (2024). Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity. Current Oncology Reports. 26(11). 1431–1441. 2 indexed citations
4.
Shaw, Heather M., Miranda Payne, Satish Kumar, et al.. (2024). A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial.. Journal of Clinical Oncology. 42(16_suppl). 9535–9535. 1 indexed citations
5.
Farag, Sheima, et al.. (2023). Hyperglycaemia following immune checkpoint inhibitor therapy—Incidence, aetiology and assessment. Diabetic Medicine. 40(4). e15053–e15053. 9 indexed citations
6.
Young, Kate, Andreas M. Schmitt, Deborah Mukherji, et al.. (2022). Management of Toxicity and Side Effects of Systemic Therapy for Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 3(6). 484–498.
7.
Andrés, María Sol, Stuart D. Rosen, John Baksi, et al.. (2022). The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment. Cardio-Oncology. 8(1). 21–21. 18 indexed citations
8.
Young, Kate, Naureen Starling, & Anguraj Sadanandam. (2019). The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities. Seminars in Cancer Biology. 61. 132–138. 9 indexed citations
9.
10.
Flynn, Michael, Kate Young, David Cunningham, & Naureen Starling. (2018). The evolving immunotherapeutic landscape in advanced oesophagogastric cancer. Therapeutic Advances in Medical Oncology. 10. 3861401268–3861401268. 6 indexed citations
11.
Young, Kate, Chanthirika Ragulan, Gift Nyamundanda, et al.. (2017). Immune landscape of pancreatic neuroendocrine tumours (PanNETs). Annals of Oncology. 28. v142–v142. 4 indexed citations
12.
Kipps, Emma, Kate Young, & Naureen Starling. (2017). Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy. Therapeutic Advances in Medical Oncology. 9(3). 159–170. 26 indexed citations
13.
Young, Kate & Ian Chau. (2015). Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions. Drugs. 76(1). 13–26. 7 indexed citations
14.
Young, Kate, Elizabeth Smyth, & Ian Chau. (2015). Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma. Therapeutic Advances in Gastroenterology. 8(6). 373–383. 17 indexed citations
15.
Young, Kate, Anna Minchom, David Cunningham, & Ian Chau. (2012). Neoadjuvant chemotherapy for gastric cancer. 1(3). 202–204. 11 indexed citations
16.
Young, Kate, Anna Minchom, & James Larkin. (2012). BRIM-1, -2 and -3 Trials: Improved Survival with Vemurafenib in Metastatic Melanoma Patients with a BRAF V600E Mutation. Future Oncology. 8(5). 499–507. 50 indexed citations
17.
Lopes, Gilberto, Joel E. Segel, Daniel S.W. Tan, et al.. (2011). Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung. Cancer. 118(4). 1032–1039. 49 indexed citations
18.
Minchom, Anna, Kate Young, & James Larkin. (2011). Ipilimumab: Showing Survival Benefit in Metastatic Melanoma. Future Oncology. 7(11). 1255–1264. 4 indexed citations
19.
20.
Sadri, Maziar, et al.. (2005). Blunt laryngeal trauma resulting in arytenoid dislocation and dysphonia. Auris Nasus Larynx. 33(1). 75–78. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fenglong Bie Breakdown of academic impact, for papers by Shuichi Tsukamoto Breakdown of academic impact, for papers by Yasunori Deguchi Breakdown of academic impact, for papers by Hirofumi Rokutan Breakdown of academic impact, for papers by Yang Lv Breakdown of academic impact, for papers by Ei Yamaki Breakdown of academic impact, for papers by Edwin A. Basak Breakdown of academic impact, for papers by Ashish Manne Breakdown of academic impact, for papers by Keiichi Akahoshi
Rankless by CCL
2026